NEWS + PRESS

Scottsdale, AZ, October 17, 2022 – Confluent Medical Technologies, Inc. (“Confluent”) today announced that Matthew K. Eckl, has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022. “We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent’s Chief Executive Officer. “Matt has exceptional experience in finance and financial ...continue reading

Confluent Medical Technologies Announces The Grand Opening Of The Newest Building At Their Large Scale Manufacturing Center Of Excellence In Alajuela, Costa Rica (Scottsdale, AZ)- Confluent Medical Technologies (Confluent), today announced the Grand Opening of the latest addition to their large scale manufacturing center of excellence in Alajuela, Costa Rica expanding their capacity for Nitinol ...continue reading

TPG investment to fuel next stage of growth and expansion for Confluent, building on its strong foundation as a leading partner to medical device manufacturers Scottsdale, AZ and San Francisco, CA, – (January 5, 2022) Confluent Medical Technologies (“Confluent”), a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), today announced that ...continue reading

Confluent Medical Technologies Unveils New Benefits Program Specifically For Their Costa Rica Location In November 2021, Confluent Medical Technologies announced several new employee benefits specifically for the Costa Rica location. These new benefits include an on-site doctor, employee birthday holiday, and free lunches for hourly employees. “It is motivating that we can see in such ...continue reading

Confluent Medical’s New Polymer Tubing Site Offers Lead Times of 4 Weeks or Less for PTFE Liners, Polyimide Tubing and Multi-layer Composite Tubing SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent”) announces today that their new High Precision Polymer Tuber center of excellence is offering lead times of 4 weeks or less. “We are excited to provide ...continue reading

Confluent Medical’s New Center of Excellence Offers Component Design Support, PTFE Liners, Polyimide Tubing and Multi-layer Composite Tubing (Scottsdale, AZ)- Confluent Medical Technologies (“Confluent”) announces today the official opening of their Chattanooga, Tenn., Specialty Medical Polymer Tubing center of excellence. This new state-of-the-art facility, expected to be operational in Q3 2021, greatly expands Confluent’s ability ...continue reading

(Scottsdale, AZ)- Confluent Medical Technologies is pleased to announce the Richard (Rich) Brown has joined the company as Senior Vice President of Quality Assurance & Regulatory Affairs. Richard comes to Confluent with over 30 years of experience in the healthcare sector. Throughout his career Rich has led multi-cultural, multi-disciplined teams through many challenging regulatory and ...continue reading

Confluent Medical Technologies Announces Expansion of the Confluent Costa Rica Manufacturing Location To Meet Growing Demand in Nitinol Processing & Specialized Catheters (Scottsdale, AZ)- Confluent Medical Technologies (Confluent), today announced a significant expansion of their Costa Rica manufacturing by adding a new facility to accommodate the increase in customer demand for specialized medical devices utilizing ...continue reading

Confluent Medical Invests in The Electrospinning Company To Expand Design Options Utilized in Structural Heart Markets SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Confluent Medical Technologies Inc. (Confluent) announced today a strategic investment in The Electrospinning Company Ltd. (Electrospinning).  Electrospinning, a UK-based company, has developed a proprietary electrospinning process which will expand the design options utilized in the structural ...continue reading

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies Inc. (“Confluent”) today announced an expansion of its supply agreement with Allegheny Technologies (ATI) related to the manufacture and supply of ELI Nitinol, a specialized metal alloy used primarily to produce high-performance minimally invasive medical devices and components. Under the revised agreement, Confluent will provide funding to increase the furnace ...continue reading